On June 14, 2021 Deracoxib Chewable tablets were approved for use in dogs for the treatment of pain and inflammation associated with OA, postoperative orthopedic surgery and dental surgery. On June 28, 2021, Carprofen Chewable tablets were approved for use in dogs for the treatment of pain and inflammation associated with OA, control of postoperative soft tissue pain, and orthopedic surgery. Both the canine pilot and pivotal bioequivalence studies for these drugs were carried out by Kingfisher International Inc. and we are proud to be part of the successful companion animal generics program at Felix Pharmaceuticals.
